Emily Hutton-Steel is a Senior Consultant in Program Management & Development Operations at Sitryx since June 2025, with prior experience as a Senior Global Program Manager at Indivior from January 2024 to June 2025. Emily has held significant roles in project management across various companies, including Associate Director of Project Management at Opiant Pharmaceuticals, where responsibilities included oversight of clinical studies for nasal nalmefene and line management. Additional experience encompasses managerial positions at BioMarin Pharmaceutical Inc., St Stephen's AIDS Trust, and Eisai EMEA, focusing on clinical operations in therapeutic areas such as rare diseases, infectious diseases, and oncology. Earlier roles include leadership in business development at Richmond Pharmacology, project management at IQVIA, and pharmacovigilance at PPD. Emily holds an MSci (Hon) in Pharmacology from the University of Glasgow.
This person is not in the org chart
This person is not in any teams
This person is not in any offices